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DNA methylation can be analyzed using a wide range of methods \[[@CR1]\], with bisulfite sequencing considered the current gold standard. Current technologies such as whole genome bisulfite sequencing (WGBS) and reduced representation bisulfite sequencing (RRBS) provide unprecedented detail of methylation patterns throughout the genome, but the complexity of DNA methylation patterns is masked when simple summary metrics are used. For example, most studies of DNA methylation rationalize levels to a percentage value, which typically masks allelic patterns when interpreting the data. We have developed Methpat, a tool that summarizes and visualizes complex DNA methylation data collected by massively parallel sequencing of bisulfite DNA \[[@CR2]\]. Using this tool, the DNA methylation state of individual CpG sites and the abundance of allelic patterns can be visualized \[[@CR3]\]. Furthermore, by measuring the abundance of allelic DNA methylation patterns, cellular heterogeneity in methylation patterns can now be explored \[[@CR4]\].

The utility of Methpat was demonstrated by measuring DNA methylation in 86 samples (Table [1](#Tab1){ref-type="table"}) across 48 regions of interest (Table [2](#Tab2){ref-type="table"}). This was achieved by using multiplex PCR on bisulfite converted DNA followed by massively parallel sequencing using an Illumina MiSeq Sequencing platform with v3 chemistry. Each sample was indexed and pooled at equimolar concentrations into a single library pool for sequencing. Data has been deposited into GEO with reference identifiers GSE67856 \[[@CR5]\] and GSE71804 \[[@CR6]\]. A panel of breast cancer cell lines treated with epidermal growth factor and transforming growth factor beta were also analyzed in parallel \[[@CR7]\].Table 1Human Samples used in this studySample NameDescriptionGEO Accession293HEK-293 embryonic kidney cell line. ATCC CRL1573GSE6785640424Normal fibroblast cell lineGSE67856910046Normal fibroblast cell lineGSE6785612A-CD19Normal Fluorescent Activated Cell Sorted (FACS) CD19 positive bone marrow cells from individual 12AGSE6785612A-CD33Normal Fluorescent Activated Cell Sorted (FACS) CD33 positive bone marrow cells from individual 12AGSE6785612A-CD34Normal Fluorescent Activated Cell Sorted (FACS) CD34 positive bone marrow cells from individual 12AGSE6785612A-CD45Normal Fluorescent Activated Cell Sorted (FACS) CD45 positive bone marrow cells from individual 12AGSE678566-MDA453MDA-MB-453 metastatic breast cancer cell line. ATCC HTB-131GSE678566C-CD19Normal Fluorescent Activated Cell Sorted (FACS) CD19 positive bone marrow cells from individual 6CGSE678566C-CD33Normal Fluorescent Activated Cell Sorted (FACS) CD33 positive bone marrow cells from individual 6CGSE678566C-CD34Normal Fluorescent Activated Cell Sorted (FACS) CD34 positive bone marrow cells from individual 6CGSE678566C-CD45Normal Fluorescent Activated Cell Sorted (FACS) CD45 positive bone marrow cells from individual 6CGSE678569A-CD19Normal Fluorescent Activated Cell Sorted (FACS) CD19 positive bone marrow cells from individual 9AGSE678569A-CD33Normal Fluorescent Activated Cell Sorted (FACS) CD33 positive bone marrow cells from individual 9AGSE678569A-CD34Normal Fluorescent Activated Cell Sorted (FACS) CD34 positive bone marrow cells from individual 9AGSE678569A-CD45Normal Fluorescent Activated Cell Sorted (FACS) CD45 positive bone marrow cells from individual 9AGSE678569A-Whole-BloodWhole blood sample from individual 9AGSE67856BRLNormal lymphoblast cell line.GSE67856CaCoCaco2 Colon cancer cell line. ATCC HTB37GSE67856DG75Lymphoblast cancer cell line. ATCC CRL-2625GSE67856EKVXCancer Cell LineGSE67856HELACancer cell line. ATCC CCL-2GSE67856HEPG2Liver cancer cell line. ATCC HB-8065GSE67856HT1080Cancer cell line. ATCC CCL121GSE67856HTB22-ColMCF7 breast cancer cell line. ATCC HTB22GSE67856JWLNormal lymphoblast cell line.GSE67856K562CML cancer cell line. ATCC CCL-243GSE67856Sample29Cell LineGSE71804MB231BAGBreast cancer cell line. ATCC HTB-26GSE67856MCF7Breast cancer cell line. ATCC HTB22GSE67856NALM6Leukaemia cell line. ACC 128GSE67856NCCITEmbryonic carcinoma cell line. ATCC CRL-2073GSE67856OVCAR8Cancer cell lineGSE67856SKNASNeuroblastoma cancer cell line. ATCC CRL2137GSE67856U231Cancer cell lineGSE67856Sample1Human normal colon tissueGSE71804Sample2Human colon tumorGSE71804Sample3Human normal colon tissueGSE71804Sample4Human colon tumorGSE71804Sample5Human normal colon tissueGSE71804Sample6Human colon tumorGSE71804Sample7Human normal colon tissueGSE71804Sample8Human colon tumorGSE71804Sample9Human normal colon tissueGSE71804Sample10Human colon tumorGSE71804Sample11Human normal colon tissueGSE71804Sample12Human colon tumorGSE71804Sample13Pooled human cancer and blood cell DNAGSE71804Sample14Pooled human cancer and blood cell DNAGSE71804Sample15Pooled human cancer and blood cell DNAGSE71804Sample16Pooled human cancer and blood cell DNAGSE71804Sample17Pooled human cancer and blood cell DNAGSE71804Sample18Pooled human cancer and blood cell DNAGSE71804Sample19Artificially methylated human DNAGSE71804Sample20Artificially methylated human DNAGSE71804Sample21Artificially methylated human DNAGSE71804Sample22Artificially methylated human DNAGSE71804Sample23Artificially methylated human DNAGSE71804Sample24Artificially methylated human DNAGSE71804Sample25Human leukemia cell lineGSE71804Sample26Human leukemia cell lineGSE71804Sample27Human leukemia cell lineGSE71804Sample28Human leukemia cell lineGSE71804468-C1-3-9_S40MDA-468 cell line, control 1GSE71804468-C2-3-9_S48MDA-468 cell line, control 2GSE71804468-S1-3-9_S56MDA-468 cell line + EGF 1GSE71804468-S2-3-9_S64MDA-468 cell line + EGF 2GSE71804ET-C1-3-9_S71PMC42-ET cell line, control 1GSE71804ET-C2-3-9_S79PMC42-ET cell line, control 2GSE71804ET-S1-3-9_S87PMC42-ET cell line, +EGF 1GSE71804ET-S2-3-9_S95PMC42-ET cell line, +EGF 2GSE71804LA-C1-3-9_S8PMC42-LA cell line, control 1GSE71804LA-C3-3-9_S16PMC42-LA cell line, control 2GSE71804LA-S1-3-9_S24PMC42-LA cell line, +EGF 1GSE71804LA-S2-3-9_S32PMC42-LA cell line, +EGF 2GSE71804PMC42ET-72-C_S31PMC42-ET cell line, control 72 hGSE71804PMC42ET-72 h-EGF_S39PMC42-ET cell line, +EGF 72 hGSE71804PMC42ET-9d-C_S47PMC42-ET cell line, control 9 daysGSE71804PMC42ET-9d-EGF_S55PMC42-ET cell line, +EGF 9 daysGSE71804PMC42ET-9d-TGFb_S63PMC42-ET cell line, +TGFb 9 daysGSE71804PMC42LA-72 h-C_S86PMC42-LA cell line, control 72 hGSE71804PMC42LA-72 h-EGF_S94PMC42-LA cell line, +EGF 72 hGSE71804PMC42LA-9d-C_S7PMC42-LA cell line, control 9 daysGSE71804PMC42LA-9d-EGF_S15PMC42-LA cell line, +EGF 9 daysGSE71804PMC42LA-9d-TGFb_S23PMC42-LA cell line, +TGFb 9 daysGSE71804Table 2Bisulfite PCR primers used in this studyPrimer namePrimer sequencePrimer TmGenomic location (hg38)mandatory01_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGAGAAGTTTGGTYGTTGYGTTTTTAT60.1--62.9mandatory01_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGRAAACCRCTCRCRAAATACCCTA57.6--64.6chr4:154710460-154710544mandatory02_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTAGYGGAGTTTAAGGGTTAGTGT59.2--60.9mandatory02_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAACRAAACRCACRTACRTATATTTATA56.3--62.1chr1:110052409-110052486mandatory03_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTGTTTGTTAGTTAGTTTTAGGTTTTTTAAT59.8mandatory03_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCTACCAAATTTCTATTACAAACCAAA60.8chr4:7526639-7526703mandatory04_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGATTTGGTTTYGAGAGTTTGGATTTT60.1--61.7mandatory04_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAAAAACCRCACACCTAAACACTTAAA60.1--61.7chr2:164593225-164593299mandatory05_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGGAATTTTGAGATTTTTAAAAGTTTTTTT59.8mandatory05_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATAAAAACAACAAATACCACTTCCTAAA59.9chr2:9518296-9518358mandatory06_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTTGYGTYGATTTTGGTTTTGGTTAT57.6--60.9mandatory06_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCRACCCCTCCCAAATCCTAAAA60.1--62.1chr17:80709100-80709203mandatory07_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGTTAGAGGAGAYGTTTTAGTTTTT59.2--60.9mandatory07_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCAATTCCAAAAAACRTCAATCACAATAA59.9--61.5chr3:142837969-142838050mandatory08_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGTTAAGAGGAGTTTGTTTTGTTTTAT60.8mandatory08_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTTTCACTAAAAAACCTCACTCCCTA60.9chr7:140218100-140218192mandatory09_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTTTTAGAGTGTTTTTGGTTTTATTATTTTT60.2mandatory09_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTATTTACCCCTAAAAATACCCTTTATA59.2chr7:26206542-26206614mandatory10_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGAAGTTGAAGTGAGAATGTGATT60.3mandatory10_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAATACCCATACAAACTATCTACACAA60.1chr7:3025554-3025664mandatory11_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTATATAAAAATTATTAAGAATTTTATTGTTTTGT58.5mandatory11_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAATATAACCAAAATCCAAATAACACTAA58.2chr7:138229946-138230021mandatory12_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGYGGYGTTTGATGGATTTGGTTT59.2--62.9mandatory12_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTTAATATAACCTAAACCCATATACTA59.2chr2:42275714-42275789mandatory13_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTAGATTATGTTAAGGATTTTGGAAAT59.2mandatory13_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTCTATACTATCAACACCCATTACTTAA60.8chr15:100249155-100249220mandatory14_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTAAATTAGATGAGGTATAGTAGATTATAT59.2mandatory14_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCAACTCTATCTCAAACTTCAAAAAATA59.2chr4:147557821-147557938mandatory15_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTTGGGGGATAGTTTTGGGTAT60.1mandatory15_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTACAACCTCCTACAAAAAAACCCTA60.9chr17:75369174-75369252mandatory16_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGATATTTTTAATTTAATTTGAAGGTTTATTGT57.8mandatory16_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCCAAACTTTCTCCTATAATCCAA60.3chr7:93520244-93520332h19_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTTTGTATTATTTTTTTTTTTGAGAGTTTATTT60.2h19_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATACRAAAAAAACCCACAATAAACTTAATA59.8--61chr11:2017873-2018050mest_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGTTTTGTTTTTTTAATTGTGTTTATTGTTT60.2mest_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTAACCACTATAACCAAAATTACACAAAA59.9chr7:130131098-130131299xist_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTAGTAATTTAGTATTGTTTATTTTATTTTTTT59xist_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATAACRAACCTCTTTATCTTTACTATATA59.2--60.5chrX:73070975-73071183runx3_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTTTAGAYGTTYGGAGTTTTAGGGT58.3--62runx3_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCRACAACCCCAACTTCCTCTA59.5--61.2chr1:25256022-25256153rarb_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAATTTTTTTATGYGAGTTGTTTGAGGAT59.9--61.5rarb_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTCCTTCCAAATAAATACTTACAAAAAA59.9chr3:25469822-25469959mlh1_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGYGGGAGGTTATAAGAGTAGGGTT60.9--62.9mlh1_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATACRAAATATCCAACCAATAAAAACAAAA59.8--61chr3:37034573-37034734rassf1a_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTTTTYGTAGTTTAATGAGTTTAGGTTTT60.5--62.1rassf1a_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAATCCCTACACCCAAATTTCCATTA60.9chr3:50378200-50378398apc_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGAGAGAGAAGTAGTTGTGTAAT60.3apc_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCATTCTATCTCCAATAACACCCTAA60.9chr5:112073447-112073596cdkn2a_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGATTTTGTTTTTTAAATTTTTTGGAGGGAT59.2cdkn2a_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCCAACCTAAAACRACTTCAAAAATA60.1--61.7chr9:21974960-21975097dapk1_p1_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTTTYGGAGTGTGAGGAGGATAGT60.9--62.9dapk1_p1_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGRACRACRAAAACACAACTAAAAAATAAATA58.5--62.6chr9:90112783-90112938dapk1_p2_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGYGGAGGGATYGGGGAGTTTTT62.1--65.5dapk1_p2_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCRCCTTAACCTTCCCAATTA63.6--65.2chr9:90112991-90113144dapk1_i1_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGAGGYGGGGAGGTTAGTTAT61.2--63.2dapk1_i1_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAAATAAAAAAAAACACCCTTTATTAAAACTAA59.8chr9:90113588-90113759gstp1_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTTTGGGAAAGAGGGAAAGGTTTTT60.3gstp1_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGRCRACCTCCRAACCTTATAAAAATAA58.4--62.9chr11:67351064-67351273cdh1_snp_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGATTTTAGTAATTTTAGGTTAGAGGGTT59.2cdh1_snp_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAAAAATAAATACRTAACTACAACCAAATAAA59--60.2chr16:68771006-68771197cdh1_3ê_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTYGGAATTGTAAAGTATTTGTGAGT60.1--61.7cdh1_3ê_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATCAAAAAATCCRAAATACCTACAACAA59.5--61.5chr16:68771201-68771385brca1_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTTTAGTTATTTGAGAAATTTTATAGTTTGTT59brca1_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAATTTCRTATTCTAAAAAACTACTACTTAA58.5--59.8chr17:41277330-41277493AluSx_1\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAGATTAGTTTGGTTAATATGGTGAAATT59.9AluSx_1\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTCTATCRCCCAAACTAAAATACAATA60.8--62.1AluSx_2\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTTTGTAATTTTAGTATTTTGGGAGGT60.8AluSx_2\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAACCTCCCRAATAACTAAAACTACAA60.1--61.7L1ME_ORF2_1\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGATGATAAAAGGGTTAATTTATTAGAAAGAT59.8L1ME_ORF2_1\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTATCTAATTATTCTRTCAATTACTAAAAA58.5--59.8L1ME_ORF2_2\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGATTGATAAAGAAGAAAATAGATAAGATAT59.8L1ME_ORF2_2\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTATTCAAATTTTCTATTTCTTTTTAAATCAA59.8foxe3_2\_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTTTTGGGGAGGTTTATTTGAGGT59.2foxe3_2\_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAACRCAAAATATACTCCAAACCAAAATA59.9--61.5chr1foxp3_1\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTTTGGGTTTAGGGTTTTATTTGTAGT59.2foxp3_1\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACCCAAAACCTCAAACCTACTAAA60.3chrXfoxp3_2\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTTTTTGGGGATGGGTTAAGGGTT60.9foxp3_2\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCAACCAATACCTACTTTAACCAAAAA60.1chrXtlx3_1\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTTYGGTTTAAGAAAGATGATATAGAGTT59.9--61.5tlx3_1\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTCCATCCTAAACRAACRAAAAAACTAA59.2--62.1chr5tlx3_2\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGYGTTAGTTATTTGGGAGGGTTT59.2--60.9tlx3_2\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAACRCTAAACTCAAATTCACACTATAAA59.5--61.5chr5uniq_noCG_1\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGAGTTATGTAGTTTTAGTTAGAAGTTT59.2uniq_noCG_1\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAAATCTAAATTTTAACACCTAAAACTATTTTAA59.8chr5uniq_noCG_2\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGATATGAAAGGTTGGTTTTATTGTTGAAT59.9uniq_noCG_2\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAAAATAAACTTAATAACTCTACTCTTATATA59chr5mgmt_1\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTTGAGTTAGGTTTTGGTAGTGTT60.3mgmt_1\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTAATACCRCTCCCCTAATCAAAA60.3--62chr10mgmt_2\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTGGTAGTTTYGAGTGGTTTTGT59.2--60.9mgmt_2\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAACTAAACAACACCTAAAAAACACTTAA59.9chr10mito_1\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTATTTATTTTTAATAGTATATAGTATATAAAGTT58.5mito_1\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACTTTAACTACCCCCAAATATTATAA58.4chrMmito_2\_plus_FTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGATGATTTTTAATAGGGGTTTTTTTAGTTT59.2mito_2\_plus_RGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCRTATCRAAAACCTTTTTAAACAAATAATA58.5--61chrM

Our initial QC assessment indicated high bisulfite conversion efficiency with very low non-CpG Cs in reads. An additional amplicon that corresponded to a sequence containing no CpG sites was also included as a control, from which all cytosines were observed to have converted to thymidine residues \[[@CR1]\].

The data included here are the Sequence Read Archive files generated from our experiment. These have been aligned onto the hg38 reference genome using Bismark v0.9.0, from which a BAM file for each sample is generated. Using the *Bismark_methylation_extractor* command, the methylation status of cytosine residues within each read is output to a tab-delimited file. Methpat then operates on this output file to generate both a summarized tab-delimited file of read pattern counts and a HTML file for visualization. We have included the BAM files, *Bismark_methylation_extractor* output files and Methpat output files as supporting data. Methpat requires a Browser Extensive Data (BED)-format-like file that contains the coordinates for each amplicon of interest, their size and their primer lengths to extract and summarize DNA methylation pattern counts. The flow of data is summarized in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Flow of data towards visualization via Methpat. Raw fastq files are aligned to the hg38 reference genome in bisulfite space. **a** hg38 reference is prepared for Bismark using *Bismark_genome_preparation* with default parameters. **b** Bismark is used to align raw reads from fastq files to generate BAM alignment files. **c** *Bismark_methylation_extractor* is then used to extract the methylation status of all cytosines in every aligned read and outputs a tab-delimited file that Methpat operates on. Methpat requires this file along with a BED formatted file containing information for each amplicon of interest. This includes the start and end coordinates of the amplicon and the primer lengths for each amplicon. The output of Methpat is a summary tab-delimited file containing read counts of DNA methylation patterns of the amplicons of interest and an HTML file for visualization and publication quality figures

Our data has the potential to be used to investigate co-methylation \[[@CR8]\], given the unprecedented depth of coverage of the amplicons investigated even in a single MiSeq run. We have interrogated a variety of regions of the genome including repetitive elements and the mitochondrial genome, which remain a challenge for most short read aligners. The interpretation of DNA methylation at repetitive sequence elements has always been a challenge and they are assumed to be methylated \[[@CR9]\]. However, the dynamics of repetitive element DNA methylation in cancer \[[@CR10]\] and development \[[@CR11]\] remain areas of interest that can now be properly interpreted with massively parallel sequencing and visualization tools such as Methpat.

Availability of software and requirements {#Sec2}
=========================================

Project name: Methpat

Project home page: <http://bjpop.github.io/methpat/>

Operating system(s): any POSIX-like operating system (i.e.: Linux, OS X)

Programming language: Python 2.7, HTML and Javascript

Other requirements: Web Browser to view visualization output (HTML file). Suggested browsers include Firefox, Chrome or Safari. Methpat requires output files derived by Bismark (<http://www.bioinformatics.babraham.ac.uk/projects/bismark/>) and the *Bismark_methylation_extractor* command. Methpat can be accessed directly from <http://bjpop.github.io/methpat/>. With further instructions found at the URL.

License: 3-clause BSD License

Any restrictions to use by non-academics: None

A flow diagram of analytical requirements and files can be found in Fig. [1](#Fig1){ref-type="fig"}.

Availability of supporting data and materials {#Sec3}
=============================================

Sequence files associated with main research publication deposited in GEO, GSE67856 \[[@CR5]\]. Remaining files are deposited in GEO, GSE71804 \[[@CR6]\].

BAM files, *bismark_methylation_extractor* output files and Methpat output files for each sample analyzed in this paper are available in the *GigaScience* GigaDB repository \[[@CR12]\].

BED

:   Browser extensible data

RRBS

:   Reduced representation bisulfite sequencing

WGBS

:   Whole genome bisulfite sequencing
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